Or, instead of a single new vaccine product being tested, researchers may invent
a new vaccine strategy using new combinations of vaccines, or new ways of giving the injections.
«
New vaccine strategy better protects high - risk cancer patients from flu.»
«Our work so far suggests that
this new vaccine strategy induces a level of virus neutralization about 25 times greater, after a single dose, than one sees in standard vaccines,» Weissman said.
In addition, Dr. Webb has been studying
new vaccine strategies to induce T cell - mediated immune responses.
Not exact matches
Thousands of deaths could be averted through a combined prevention and treatment
strategy — interventions such as improved mother and child nutrition, optimal breastfeeding practices; Oral Rehydration Therapy [ORT];
new low - osmolarity formulations of ORS; incorporating rotavirus
vaccines; zinc supplementation during diarrhoea episodes; immunizing all children against measles; appropriate drug therapy; increased access to safe clean water and sanitation facilities and improved personal and domestic hygiene, including keeping food and water clean and washing hands before touching food.
At 10:30 a.m., U.S. Senate Minority Leader U.S. Chuck Schumer will urge the U.S. Department of Health and Human Services to increase research,
vaccine development and treatment
strategies to help stamp out tick - borne diseases like Lyme disease, Albany Medical Center, B Entry, Patient Pavilion, Floor E, corner of Myrtle Avenue and
New Scotland Avenue, Albany.
He said that the most exciting arenas of immunology today include
new strategies for
vaccines and studies of regulatory T lymphocytes and the innate immune response, which is essentially the most general form of attacking pathogens.
With all of the interest in developing
new therapeutics,
new vaccines, and
strategies for fighting bioterrorism, immunology poses many serious questions for scientists.
«While awaiting development of
new vaccines that will provide longer - lasting protection against pertussis, we should consider alternate Tdap immunization
strategies for adolescents.»
This could lead to
new HIV
vaccine strategies that are able to stimulate the rare precursors of these protective antibodies,» says Professor Lynn Morris, from the National Health Laboratory Service in the Wits School of Pathology who leads the research team at the NICD.
Nevertheless, he believes that the
new research may eventually lead to
strategies for preventing MS. «In cases where multiple sclerosis runs in families, one could identify children who have inherited high - risk genes, and give them preventive
vaccines,» he says.
Recent research has yielded
new information about immune responses associated with — and potentially responsible for — protection from HIV infection, providing leads for
new strategies to develop an HIV
vaccine.
«
New strategy could yield more precise seasonal flu
vaccine.»
«Developing a
new vaccination
strategy against AIDS: The type of
vaccine administered and the activation of the body's own immune cells influence the
vaccine protection.»
«Bringing the global HIV epidemic under control requires
new tools, bold
strategies and collaboration among a number of stakeholders,» said Hanneke Schuitemaker, one of the study authors and vice president, Viral
Vaccines Discovery and Translational Medicine, Janssen.
Now researchers have used a
new strategy to develop a
vaccine that protects mice from multiple variants of the Strep B bug, which kills around 100 newborns in the United States each year.
The current epizootic in the Far East caused by avian influenza virus A (H5N1) has led to real concern about the possibility of a
new pandemic of influenza.12 Technological innovation, such as the use of
new vaccines delivered by the intradermal route, offers great promise to change and improve on current immunization
strategies.
«To date, neither antiviral drugs nor
vaccines are approved for clinical use against human parainfluenza virus, which reinforces the urgent need for
new therapeutic discovery
strategies.
In the
new issue of IAVI Report we wrote about how researchers at the AIDS
Vaccine 2010 conference in Atlanta discussed the limited window of opportunity for conducting clinical trials to test partially effective HIV prevention strategies, including HIV vaccine candidates and oral or topical antiretroviral pre-exposure prophylaxis (PrEP), in combi
Vaccine 2010 conference in Atlanta discussed the limited window of opportunity for conducting clinical trials to test partially effective HIV prevention
strategies, including HIV
vaccine candidates and oral or topical antiretroviral pre-exposure prophylaxis (PrEP), in combi
vaccine candidates and oral or topical antiretroviral pre-exposure prophylaxis (PrEP), in combination.
Ghana's
strategy, President Akufo - Addo said, was based on innovations — adopting the
new generation of insecticides for indoor - residual spraying, as well as being one of the three countries testing the
new malaria
vaccine.
The World Health Organization's End TB
Strategy states that a
new, more effective
vaccine is essential to ending TB.
The finding points to a possible
new strategy in the search for an effective AIDS
vaccine.
These could include targeted probiotic therapy, novel
vaccines or
vaccine strategies and
new therapeutics to treat LRTI.
Studies conducted and supported by NIAID have led to important
new discoveries about the microbes that cause NTDs, the identification of targets for potential
new drugs and
vaccines, and the development of
strategies for controlling organisms that transmit NTD - causing agents to humans.
Within the fields of microbiology and immunology, neurologic diseases, neuropharmacology, behavioral, cognitive and developmental neuroscience, and psychiatric disorders, the center's research programs are seeking ways to: develop
vaccines for infectious and noninfectious diseases; understand the basic neurobiology and genetics of social behavior and develop
new treatment
strategies for improving social functioning in social disorders such as autism; interpret brain activity through imaging; increase understanding of progressive illnesses such as Alzheimer's and Parkinson's diseases; unlock the secrets of memory; treat drug addiction; determine how the interaction between genetics and society shape who we are; and advance knowledge about the evolutionary links between biology and behavior.
The knowledge of the pathogenic mechanisms of infection and disease guide the development of intervention and prevention
strategies and
new HIV
vaccine candidates.
By analyzing the molecular aspects of the extensive immune crosstalk between the fungal pathogen and the human host allows to define novel evasion
strategies and defines
new molecules which can serve as useful markers to develop
new antifungal compounds and
vaccine candidates.
BPRC applies molecular, biochemical and immunological know - how to provide
new vaccine and therapeutic
strategies for malaria, tuberculosis, HIV, hepatitis C and other infectious diseases.
As partner of TRANSVAC, IRTA will provide access to their animal facilities (CReSA) to carry out safety and immunogenicity studies of
new candidate
vaccines and / or of novel vaccination (administration)
strategies in pigs, ferrets and other large animal species.
The access includes animal breeding, housing, caretaking and biotechnical expertise for mouse studies on a
vaccine candidate (provided by the user) including sampling and standard immune monitoring to carry out validation experiments of the
new vaccine candidate or vaccination
strategies of the potential user.
As partner of TRANSVAC2, WBVR will provide access to their animal facilities (Lelystad) to carry out immunogenicity and efficacy studies of
new candidate
vaccines and / or of novel vaccination (administration)
strategies in pigs, cattle, ferrets or other animal species.
Our veterinarians perform a full examination of your pet and discuss with you vital information about your
new pet, including
vaccine schedules, heartworm disease and other parasites, your puppy's or kitten's nutritional needs, house training
strategies and more.
Glenn, G. M., Taylor, D.N., Lang, D. Transcutaneous immunization: A
new vaccine delivery
strategy.